Phuong N. Huynh

Array ( [id] => 6581695 [patent_doc_number] => 20100291103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/663505 [patent_app_country] => US [patent_app_date] => 2008-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 91 [patent_no_of_words] => 53505 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291103.pdf [firstpage_image] =>[orig_patent_app_number] => 12663505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791645 [patent_doc_number] => 20080292618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'INTRANUCLEAR PROTEIN TRANSDUCTION THROUGH A NUCLEOSIDE SALVAGE PATHWAY' [patent_app_type] => utility [patent_app_number] => 12/126810 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23035 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292618.pdf [firstpage_image] =>[orig_patent_app_number] => 12126810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4851981 [patent_doc_number] => 20080317723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'LYMPHATIC ENDOTHELIAL CELLS MATERIALS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/125572 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 31494 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317723.pdf [firstpage_image] =>[orig_patent_app_number] => 12125572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6528178 [patent_doc_number] => 20100203653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Protein G-Oligonucleotide Conjugate' [patent_app_type] => utility [patent_app_number] => 12/665397 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6074 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203653.pdf [firstpage_image] =>[orig_patent_app_number] => 12665397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6295254 [patent_doc_number] => 20100160228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'METHOD FOR INHIBITING OR STIMULATING ANGIOGENESIS IN AN INDIVIDUAL' [patent_app_type] => utility [patent_app_number] => 12/601108 [patent_app_country] => US [patent_app_date] => 2008-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9193 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160228.pdf [firstpage_image] =>[orig_patent_app_number] => 12601108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681901 [patent_doc_number] => 20080248127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Standardized bee venom preparation' [patent_app_type] => utility [patent_app_number] => 12/152216 [patent_app_country] => US [patent_app_date] => 2008-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6272 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248127.pdf [firstpage_image] =>[orig_patent_app_number] => 12152216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5503010 [patent_doc_number] => 20090163698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Method for Preparing Antibody Conjugates' [patent_app_type] => utility [patent_app_number] => 12/119025 [patent_app_country] => US [patent_app_date] => 2008-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20636 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163698.pdf [firstpage_image] =>[orig_patent_app_number] => 12119025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336753 [patent_doc_number] => 20090053217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Human anti-VEGF polyclonal antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/149766 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9317 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053217.pdf [firstpage_image] =>[orig_patent_app_number] => 12149766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271530 [patent_doc_number] => 20090075306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DIAGNOSTIC ASSAY FOR DETECTING AND MONITORING AGE RELATED AND NOISE INDUCED HEARING LOSS' [patent_app_type] => utility [patent_app_number] => 12/116555 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6110 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075306.pdf [firstpage_image] =>[orig_patent_app_number] => 12116555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943535 [patent_doc_number] => 20110104155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'DRUG DELIVERY TO THE ANTERIOR AND POSTERIOR SEGMENTS OF THE EYE USING EYE DROPS' [patent_app_type] => utility [patent_app_number] => 12/921958 [patent_app_country] => US [patent_app_date] => 2008-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 13843 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104155.pdf [firstpage_image] =>[orig_patent_app_number] => 12921958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791670 [patent_doc_number] => 20080292643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'LEUKOCYTE INACTIVATION MODULE' [patent_app_type] => utility [patent_app_number] => 12/114349 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1224 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292643.pdf [firstpage_image] =>[orig_patent_app_number] => 12114349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82627 [patent_doc_number] => 07740844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Anti-VEGF monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 12/111606 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 4779 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/740/07740844.pdf [firstpage_image] =>[orig_patent_app_number] => 12111606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726702 [patent_doc_number] => 20080206243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Methods for Treating Kidney Disorders' [patent_app_type] => utility [patent_app_number] => 12/110042 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 37027 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206243.pdf [firstpage_image] =>[orig_patent_app_number] => 12110042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4498791 [patent_doc_number] => 07919248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Methods for the modulation of IL-13' [patent_app_type] => utility [patent_app_number] => 12/109780 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11373 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919248.pdf [firstpage_image] =>[orig_patent_app_number] => 12109780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6322969 [patent_doc_number] => 20100113746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'PROCESS FOR PURIFICATION OF IMMUNOGLOBULINS USING A PSEUDOBIOAFFINITY ADSORBENT' [patent_app_type] => utility [patent_app_number] => 12/597136 [patent_app_country] => US [patent_app_date] => 2008-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8979 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113746.pdf [firstpage_image] =>[orig_patent_app_number] => 12597136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9238684 [patent_doc_number] => 08603473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Modified binding molecules comprising connecting peptides' [patent_app_type] => utility [patent_app_number] => 12/100375 [patent_app_country] => US [patent_app_date] => 2008-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 44 [patent_no_of_words] => 50284 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12100375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887865 [patent_doc_number] => 20080262197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'METHODS AND MATERIALS FOR TREATING INFLAMMATORY CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/099332 [patent_app_country] => US [patent_app_date] => 2008-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11468 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262197.pdf [firstpage_image] =>[orig_patent_app_number] => 12099332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675643 [patent_doc_number] => 20080213272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'VEGF-RELATED PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/062184 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25909 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213272.pdf [firstpage_image] =>[orig_patent_app_number] => 12062184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292637 [patent_doc_number] => 20100239588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'THE FUNCTIONAL EPITOPE OF OSTEOPONTIN, THE ANTI-OSTEOPONTIN MONOCLONAL ANTIBODY AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/597391 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17740 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239588.pdf [firstpage_image] =>[orig_patent_app_number] => 12597391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977050 [patent_doc_number] => 09023356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Treatment method using EGFR antibodies and SRC inhibitors and related formulations' [patent_app_type] => utility [patent_app_number] => 12/450196 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17271 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12450196 [rel_patent_id] =>[rel_patent_doc_number] =>)